| Team | M | W | L | T | NR | NRR | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Equity | 4 | 4 | 0 | 0 | 0 | 0 | 8 | 136/15.4 | 118/20 | 8 | W-W-W-W |  | ||
| 2 | Finance | 4 | 3 | 1 | 0 | 0 | 0 | 6 | 133/16.1 | 131/19.4 | 6 | L-W-W-W | | ||
| 3 | IT-1 | 4 | 2 | 2 | 0 | 0 | 0 | 4 | 162/20 | 140/17.4 | 4 | W-L-L-W | | ||
| 4 | FID | 4 | 1 | 3 | 0 | 0 | 0 | 2 | 158/19 | 160/16.4 | 2 | L-W-L-L | | ||
| 5 | IB-2 | 4 | 0 | 4 | 0 | 0 | 0 | 0 | 102/20 | 142/16.5 | 0 | L-L-L-L | |
| Team | M | W | L | T | NR | NRR | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Corporate | 4 | 4 | 0 | 0 | 0 | 0 | 8 | 214/20 | 134/20 | 8 | W-W-W-W | | ||
| 2 | Research | 4 | 3 | 1 | 0 | 0 | 0 | 6 | 173/17.3 | 106/20 | 6 | W-W-L-W | | ||
| 3 | IB-1 | 4 | 2 | 2 | 0 | 0 | 0 | 4 | 146/20 | 179/20 | 4 | L-L-W-W | | ||
| 4 | OPS&Others | 4 | 1 | 3 | 0 | 0 | 0 | 2 | 151/18.5 | 165/17.3 | 2 | L-L-W-L | | ||
| 5 | IT-2 | 4 | 0 | 4 | 0 | 0 | 0 | 0 | 135/20 | 235/18.5 | 0 | L-L-L-L | |
